Home › Companies › BICYCLE THERAPEUTICS PLC › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and BICYCLE THERAPEUTICS PLC’s Form 8-K, filed June 17, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 17, 2025: 9 items on BICYCLE THERAPEUTICS PLC’s Form 8-K, filed June 17, 2025: 9 passed (calculated).
Notable dissent: 1 equity or compensation plan (22.4% against); 1 other board item (18.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore BICYCLE THERAPEUTICS PLC in the interactive database Compare manager voting policies
These tallies are BICYCLE THERAPEUTICS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. To re-elect as a director Alessandro Riva | 40,034,345 | 9,086,349 | 14,365 | -- | -- | 82% | Passed (calculated) | — |
| 2. To re-elect as a director Stephen Sands | 47,652,747 | 1,481,237 | 1,075 | -- | -- | 97% | Passed (calculated) | — |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement | 47,287,428 | 1,743,008 | 104,623 | -- | -- | 96% | Passed (calculated) | — |
| 4. To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S | 49,093,195 | 41,363 | 501 | -- | -- | 99.9% | Passed (calculated) | — |
| 5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K | 49,094,477 | 40,022 | 560 | -- | -- | 99.9% | Passed (calculated) | — |
| 6. To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K | 49,116,858 | 17,701 | 500 | -- | -- | 99.9% | Passed (calculated) | — |
| 7. To receive and adopt the Company's U.K | 49,001,464 | 133,090 | 505 | -- | -- | 99.7% | Passed (calculated) | — |
| 8. To approve the directors' remuneration report for the year ended December 31, 2024, which report is set forth in the Company's definitive proxy statement | 47,393,255 | 1,733,604 | 8,200 | -- | -- | 96% | Passed (calculated) | — |
| 9. To approve an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth in the Company's definitive proxy statement | 38,137,068 | 10,979,123 | 18,868 | -- | -- | 78% | Passed (calculated) | — |
Source: BICYCLE THERAPEUTICS PLC, Form 8-K, filed with the SEC on June 17, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
108 asset managers disclosed a vote on at least one BICYCLE THERAPEUTICS PLC item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BICYCLE THERAPEUTICS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: To re-elect Alessandro Riva as a director, who retires in accordance with the Articles of Association.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“1. To re-elect as a director Alessandro Riva”): 40,034,345 for, 9,086,349 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 1,509,646 for, 1,650,404 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,231,314 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 0 | 1,000,820 | 0 | 0 | Against |
| Principal | 0 | 293,300 | 0 | 0 | Against |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 91,153 | 53,054 | 0 | 0 | Mixed |
| Goldman Sachs | 0 | 100,250 | 0 | 0 | Against |
| Morgan Stanley | 0 | 58,724 | 0 | 0 | Against |
| State Street | 1,268 | 30,155 | 0 | 0 | Against |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 0 | 25,352 | 0 | 0 | Against |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0 | 21,900 | 0 | 0 | Against |
| Harbor ETF Trust | 0 | 16,482 | 0 | 0 | Against |
| Listed Funds Trust | 0 | 14,396 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 12,764 | 0 | 0 | Against |
| STEWARD FUNDS, INC. | 0 | 11,209 | 0 | 0 | Against |
| Equitable | 11,014 | 0 | 0 | 0 | For |
| Mercer Funds | 0 | 5,511 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 4,131 | 0 | 0 | Against |
| ProShares | 0 | 1,779 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 300 | 0 | 0 | Against |
| Fidelity | 0 | 277 | 0 | 0 | Against |
| CITY NATIONAL ROCHDALE FUNDS | 45 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To re-elect Stephen Sands as a director, who retires in accordance with the Articles of Association.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“2. To re-elect as a director Stephen Sands”): 47,652,747 for, 1,481,237 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 3,067,629 for, 92,421 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,231,314 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,000,820 | 0 | 0 | 0 | For |
| Principal | 293,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 53,054 | 91,153 | 0 | 0 | Mixed |
| Goldman Sachs | 100,250 | 0 | 0 | 0 | For |
| Morgan Stanley | 58,724 | 0 | 0 | 0 | For |
| State Street | 30,155 | 1,268 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 25,352 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 21,900 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,482 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,764 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| Equitable | 11,014 | 0 | 0 | 0 | For |
| Mercer Funds | 5,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,131 | 0 | 0 | 0 | For |
| ProShares | 1,779 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 300 | 0 | 0 | 0 | For |
| Fidelity | 277 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 45 | 0 | 0 | 0 | For |
99.7% Majority: yes · of votes cast
Description as filed by funds: To receive and adopt our U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. Annual Report").
BICYCLE THERAPEUTICS PLC’s own tally for this item (“7. To receive and adopt the Company's U.K”): 49,001,464 for, 133,090 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 3,160,050 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,231,314 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,000,820 | 0 | 0 | 0 | For |
| Principal | 293,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 144,207 | 0 | 0 | 0 | For |
| Goldman Sachs | 100,250 | 0 | 0 | 0 | For |
| Morgan Stanley | 58,724 | 0 | 0 | 0 | For |
| State Street | 31,423 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 25,352 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 21,900 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,482 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,764 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| Equitable | 11,014 | 0 | 0 | 0 | For |
| Mercer Funds | 5,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,131 | 0 | 0 | 0 | For |
| ProShares | 1,779 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 300 | 0 | 0 | 0 | For |
| Fidelity | 277 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 45 | 0 | 0 | 0 | For |
78% Majority: yes · of votes cast
Description as filed by funds: To approve an amendment to our Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth as Annex C to the proxy statement.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“9. To approve an amendment to the Company's Amended and Restated 2020 Equity Incentive Plan, which amendment is set forth in the Company's definitive proxy statement”): 38,137,068 for, 10,979,123 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 23 asset managers below reported 149,250 for, 3,010,946 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 1,231,314 | 0 | 0 | Against |
| HARBOR FUNDS | 0 | 1,000,820 | 0 | 0 | Against |
| Principal | 0 | 293,300 | 0 | 0 | Against |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 0 | 144,207 | 0 | 0 | Against |
| Goldman Sachs | 0 | 100,250 | 0 | 0 | Against |
| Morgan Stanley | 0 | 58,724 | 0 | 0 | Against |
| State Street | 0 | 31,423 | 0 | 0 | Against |
| John Hancock | 0 | 25,602 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 0 | 25,352 | 0 | 0 | Against |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0 | 21,900 | 0 | 0 | Against |
| Harbor ETF Trust | 0 | 16,482 | 0 | 0 | Against |
| Listed Funds Trust | 0 | 14,396 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 12,764 | 0 | 0 | Against |
| STEWARD FUNDS, INC. | 0 | 11,209 | 0 | 0 | Against |
| Equitable | 0 | 11,014 | 0 | 0 | Against |
| Mercer Funds | 0 | 5,511 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 4,131 | 0 | 0 | Against |
| ProShares | 0 | 1,779 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 300 | 0 | 0 | Against |
| Fidelity | 0 | 277 | 0 | 0 | Against |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 0 | 146 | 0 | 0 | Against |
| CITY NATIONAL ROCHDALE FUNDS | 0 | 45 | 0 | 0 | Against |
Combines 8 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 96.8% for (May 16, 2024 meeting) ▼ 0.3 pts
Description as filed by funds: TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement”): 47,287,428 for, 1,743,008 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,231,314 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,000,820 | 0 | 0 | 0 | For |
| Principal | 293,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 144,207 | 0 | 0 | 0 | For |
| Goldman Sachs | 100,250 | 0 | 0 | 0 | For |
| Morgan Stanley | 58,724 | 0 | 0 | 0 | For |
| State Street | 31,423 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 25,352 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 21,900 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,482 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,764 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| Equitable | 11,014 | 0 | 0 | 0 | For |
| Mercer Funds | 5,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,131 | 0 | 0 | 0 | For |
| ProShares | 1,779 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 300 | 0 | 0 | 0 | For |
| Fidelity | 277 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 45 | 0 | 0 | 0 | For |
Fund voting reports, all 22 managers: 3,160,050 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 10,885,357 | 0 | 0 | 0 | For |
| FCPM III SERVICES B.V. | 3,452,330 | 0 | 0 | 0 | For |
| Point72 | 3,296,624 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 2,162,468 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,113,223 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 1,552,106 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,528,984 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 1,054,752 | 0 | 0 | Against |
| EcoR1 Capital, LLC | 910,000 | 0 | 0 | 0 | For |
| AXA INVESTMENT MANAGERS UK Ltd | 0 | 553,682 | 0 | 0 | Against |
| Deep Track Capital, LP | 485,355 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 408,296 | 0 | 0 | 0 | For |
| Woodline Partners LP | 362,325 | 0 | 0 | 0 | For |
| COMERICA BANK | 306,779 | 0 | 0 | 0 | For |
| PLATINUM INVESTMENT MANAGEMENT LTD | 287,599 | 0 | 0 | 0 | For |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 134,059 | 0 | 0 | 0 | For |
| Renaissance | 121,660 | 0 | 0 | 0 | For |
| PINNACLE ASSOCIATES LTD | 106,155 | 0 | 0 | 0 | For |
| Janney Montgomery Scott LLC | 105,978 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 83,741 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 80,799 | 0 | 0 | 0 | For |
| Allianz | 73,100 | 0 | 0 | 0 | For |
| Citadel | 66,459 | 0 | 0 | 0 | For |
| BESSEMER INVESTMENT MANAGEMENT LLC | 50,704 | 0 | 0 | 0 | For |
| Bessemer Trust Co of California, N.A. | 50,704 | 0 | 0 | 0 | For |
Institutional-manager reports, all 89 managers: 28,868,419 for, 1,609,154 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE OUR DIRECTORS' REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 (THE "DIRECTORS' REMUNERATION REPORT"), WHICH IS SET FORTH AS ANNEX A TO THE PROXY STATEMENT.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“8. To approve the directors' remuneration report for the year ended December 31, 2024, which report is set forth in the Company's definitive proxy statement”): 47,393,255 for, 1,733,604 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,231,314 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,000,820 | 0 | 0 | 0 | For |
| Principal | 293,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 144,207 | 0 | 0 | 0 | For |
| Goldman Sachs | 100,250 | 0 | 0 | 0 | For |
| Morgan Stanley | 58,724 | 0 | 0 | 0 | For |
| State Street | 31,423 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 25,352 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 21,900 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,482 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,764 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| Equitable | 11,014 | 0 | 0 | 0 | For |
| Mercer Funds | 5,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,131 | 0 | 0 | 0 | For |
| ProShares | 1,779 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 300 | 0 | 0 | 0 | For |
| Fidelity | 277 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 45 | 0 | 0 | 0 | For |
Fund voting reports, all 22 managers: 3,160,050 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Siren, L.L.C. | 1,552,106 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 248,934 | 0 | 0 | 0 | For |
| WOODSTOCK CORP | 24,981 | 0 | 0 | 0 | For |
| BlackRock | 22,806 | 0 | 0 | 0 | For |
| Argent Trust Co | 1,690 | 0 | 0 | 0 | For |
| ADVISOR PARTNERS II, LLC | 1,173 | 0 | 0 | 0 | For |
| Granahan Investment Management, LLC | 404 | 0 | 0 | 0 | For |
| HANCOCK WHITNEY CORP | 200 | 0 | 0 | 0 | For |
| Sonora Investment Management Group, LLC | 100 | 0 | 0 | 0 | For |
| Chicago Partners Investment Group LLC | 22 | 0 | 0 | 0 | For |
Institutional-manager reports, all 10 managers: 1,852,416 for.
99.9% Majority: yes · of votes cast
Description as filed by funds: To authorize the Audit Committee to determine our U.K. statutory auditors' remuneration for the year ending December 31, 2025.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“6. To authorize the Audit Committee of the Company's Board of Directors (the "Board") to determine the Company's U.K”): 49,116,858 for, 17,701 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 3,160,050 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,231,314 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,000,820 | 0 | 0 | 0 | For |
| Principal | 293,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 144,207 | 0 | 0 | 0 | For |
| Goldman Sachs | 100,250 | 0 | 0 | 0 | For |
| Morgan Stanley | 58,724 | 0 | 0 | 0 | For |
| State Street | 31,423 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 25,352 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 21,900 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,482 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,764 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| Equitable | 11,014 | 0 | 0 | 0 | For |
| Mercer Funds | 5,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,131 | 0 | 0 | 0 | For |
| ProShares | 1,779 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 300 | 0 | 0 | 0 | For |
| Fidelity | 277 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 45 | 0 | 0 | 0 | For |
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2025.
The 22 asset managers below reported 3,160,050 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,231,314 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,000,820 | 0 | 0 | 0 | For |
| Principal | 293,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 144,207 | 0 | 0 | 0 | For |
| Goldman Sachs | 100,250 | 0 | 0 | 0 | For |
| Morgan Stanley | 58,724 | 0 | 0 | 0 | For |
| State Street | 31,423 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 25,352 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 21,900 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,482 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,764 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| Equitable | 11,014 | 0 | 0 | 0 | For |
| Mercer Funds | 5,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,131 | 0 | 0 | 0 | For |
| ProShares | 1,779 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 300 | 0 | 0 | 0 | For |
| Fidelity | 277 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 45 | 0 | 0 | 0 | For |
99.9% Majority: yes · of votes cast
Description as filed by funds: To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.
BICYCLE THERAPEUTICS PLC’s own tally for this item (“5. To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K”): 49,094,477 for, 40,022 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 3,160,050 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 1,231,314 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,000,820 | 0 | 0 | 0 | For |
| Principal | 293,300 | 0 | 0 | 0 | For |
| Harbor Funds II | 149,250 | 0 | 0 | 0 | For |
| BlackRock | 144,207 | 0 | 0 | 0 | For |
| Goldman Sachs | 100,250 | 0 | 0 | 0 | For |
| Morgan Stanley | 58,724 | 0 | 0 | 0 | For |
| State Street | 31,423 | 0 | 0 | 0 | For |
| John Hancock | 25,602 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 25,352 | 0 | 0 | 0 | For |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 21,900 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 16,482 | 0 | 0 | 0 | For |
| Listed Funds Trust | 14,396 | 0 | 0 | 0 | For |
| ETF Series Solutions | 12,764 | 0 | 0 | 0 | For |
| STEWARD FUNDS, INC. | 11,209 | 0 | 0 | 0 | For |
| Equitable | 11,014 | 0 | 0 | 0 | For |
| Mercer Funds | 5,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 4,131 | 0 | 0 | 0 | For |
| ProShares | 1,779 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 300 | 0 | 0 | 0 | For |
| Fidelity | 277 | 0 | 0 | 0 | For |
| CITY NATIONAL ROCHDALE FUNDS | 45 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 69,202,355 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 1.78% |
| 2 | HARBOR FUNDS | 1.45% |
| 3 | Principal | 0.42% |
| 4 | Harbor Funds II | 0.22% |
| 5 | BlackRock | 0.21% |
| 6 | Goldman Sachs | 0.14% |
| 7 | Morgan Stanley | 0.08% |
| 8 | State Street | 0.05% |
| 9 | John Hancock | 0.04% |
| 10 | OLD WESTBURY FUNDS INC | 0.04% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 15.73% |
| 2 | FCPM III SERVICES B.V. | 4.99% |
| 3 | Point72 | 4.76% |
| 4 | ARMISTICE CAPITAL, LLC | 3.12% |
| 5 | WESTFIELD CAPITAL MANAGEMENT CO LP | 3.05% |
| 6 | Siren, L.L.C. | 2.24% |
| 7 | T. Rowe Price | 2.21% |
| 8 | BNP Paribas Asset Management Holding S.A. | 1.52% |
| 9 | EcoR1 Capital, LLC | 1.31% |
| 10 | AXA INVESTMENT MANAGERS UK Ltd | 0.80% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Point72 | 3,692,069 | 5.34% | Form 13F, quarter ended March 31, 2025 |
| Armistice Capital, LLC | 3,398,000 | 4.91% | Schedule 13G, filed May 15, 2026 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 3,310,687 | 4.78% | Schedule 13G, filed May 15, 2026 |
| Raymond Debbane | 1,560,882 | 2.26% | Schedule 13G, filed May 4, 2026 |
| T. Rowe Price | 1,536,584 | 2.22% | Form 13F, quarter ended March 31, 2025 |
| Morgan Stanley | 999,837 | 1.44% | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 322,876 | 0.47% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 301,500 | 0.44% | Form 13F, quarter ended March 31, 2025 |
| Citadel Advisors | 165,370 | 0.24% | Form 13F, quarter ended March 31, 2025 |
| State Street | 85,653 | 0.12% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 69,202,355 shares outstanding, as reported by BICYCLE THERAPEUTICS PLC on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At BICYCLE THERAPEUTICS PLC's shareholder meeting held June 17, 2025, in the 2024-2025 proxy season, 108 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 359 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, ON ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED… — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BICYCLE THERAPEUTICS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BICYCLE THERAPEUTICS PLC’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
BICYCLE THERAPEUTICS PLC proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “BICYCLE THERAPEUTICS (BCYC) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/bicycle-therapeutics-plc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.